PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 123 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,250,000 | +24.0% | 513,375 | -17.4% | 0.06% | +17.0% |
| Q2 2016 | $2,622,000 | -1.9% | 621,357 | +1.3% | 0.05% | -1.9% |
| Q1 2016 | $2,673,000 | -29.8% | 613,161 | -1.2% | 0.05% | -29.9% |
| Q4 2015 | $3,805,000 | +6.8% | 620,751 | -0.3% | 0.08% | +5.5% |
| Q3 2015 | $3,562,000 | +112.2% | 622,775 | +176.8% | 0.07% | +143.3% |
| Q2 2015 | $1,679,000 | – | 225,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |